Direct-acting oral anti-coagulants in dental practice: A Retrospective Observational Study (Part 1)

Objectives The objective of this retrospective observational study was to determine the incidence of direct-acting oral anti-coagulant (DOA) use in patients receiving invasive dental procedures. The secondary objective was to investigate the precautionary measures implemented and the post/intraoperative complications associated with DOA use. Methods Electronic record database, Axium, was retrospectively reviewed, and patients using NGOA and treated between 2010 and 2017 were identified. Charts of patients who underwent invasive dental procedures were further reviewed to investigate the preoperative/intraoperative precautionary measures taken and identify any intraoperative/postoperative complications. Results A total of 130 patients were identified, with their annual number steadily rising from 12 in 2011 to 52 in 2016. Among those, 64 patients (49.23%) underwent invasive dental procedures. Pretreatment medical consults were obtained in all patients undergoing invasive procedures; however, only 7 (10.94%) were instructed to discontinue their DOA. Preoperative laboratory testing was obtained for two patients. Intraoperatively, 34 (53.13%) cases of excessive bleeding were reported, all were locally controlled with hemostatic agents. Only 4 instances of postoperative complications were documented. Conclusions Despite the rise in the use of DOA, there is no consistent pattern for preoperative laboratory testing and DOA discontinuations. Expert consensus may be of great importance to develop practice guidelines.

Automated summary

This retrospective observational study aimed to determine the incidence of direct-acting oral anti-coagulant (DOA) use in patients undergoing invasive dental procedures. The study found that despite the increase in DOA usage, there is no consistent approach to preoperative laboratory testing and DOA discontinuations. Most cases of excessive bleeding during procedures were locally controlled with hemostatic agents, with a low incidence of postoperative complications.